PBM Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

10.529

Open

9.819

VWAP

8.41

Vol

50.09M

Mkt Cap

8.72M

Low

7.110

Amount

421.44M

EV/EBITDA(TTM)

--

Total Shares

1.15M

EV

6.33M

EV/OCF(TTM)

--

P/S(TTM)

--

Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Show More

Events Timeline

(ET)

2026-04-17

15:10:00

Psyence Biomedical Ltd Trading Halted Due to Volatility Trading Pause

2026-04-17

10:00:00

Trump Administration to Examine Ibogaine Drug Safety

2026-04-17

09:30:00

Psyence Biomedical Welcomes U.S. Evaluation of Ibogaine Safety

2026-04-16 (ET)

2026-04-16

12:10:00

White House Considers Safety Review of Ibogaine

2026-03-03 (ET)

2026-03-03

09:20:00

Psyence Biomedical Exports NPX-5 Product to Australia

2026-02-17 (ET)

2026-02-17

09:30:00

Psyence Biomedical Announces Voting Results from Annual Shareholders Meeting

2026-02-13 (ET)

2026-02-13

18:40:00

Psyence Biomedical Enters Put Option Agreement with PsyLabs

News

Newsfilter

04-17Newsfilter

PinnedPsyence BioMed Welcomes U.S. Executive Order on Ibogaine Research

Yahoo Finance

04-18Yahoo Finance

Trump Administration to Examine Safety of Psychedelic Drug for PTSD

Yahoo Finance

04-17Yahoo Finance

Health Care Stocks Rise 1.4% on NYSE

stocktwits

04-17stocktwits

Trump to Sign Executive Order on Psychedelic Research

NASDAQ.COM

04-17NASDAQ.COM

Psyence Supports U.S. Regulated Research on Ibogaine

stocktwits

04-17stocktwits

Israel-Lebanon Ceasefire Boosts Market Sentiment

Valuation Metrics

The current forward P/E ratio for Psyence Biomedical Ltd (PBM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Psyence Biomedical Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

top moving penny stocks

Intellectia · 735 candidates

Market Cap: <= 5.00BPrice: $0.00 - $10.00Volume: >= 50,000Price Change Pct: >= $2.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

6.73M

YXT.Com Group Holding Ltd

22.01M

U Power Ltd

2.90M

Blaize Holdings Inc

212.35M

Lifezone Metals Ltd

349.64M

FGI Industries Ltd

9.33M

list all stock up 5% premarket

Intellectia · 156 candidates

Pre Market Price Change: >= $5.00

Ticker

Name

Market Cap$

Energy Focus Inc

13.18M

Psyence Biomedical Ltd

6.73M

YXT.Com Group Holding Ltd

22.01M

iSpecimen Inc

3.46M

Lifezone Metals Ltd

349.64M

WeShop Holdings Ltd

334.42M

stocks under $1 that fell 5% or more

Intellectia · 66 candidates

Price: <= $1.00Price Change Pct: <= $-5.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Super League Enterprise Inc

5.88M

Skycorp Solar Group Ltd

11.55M

stocks under $2 that fell 5% or more

Intellectia · 109 candidates

Price: <= $2.00Price Change Pct: <= $-5.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Venus Concept Inc

3.51M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Surgepays Inc

25.72M

find stocks under $2 that fell 5% or more

Intellectia · 109 candidates

Price: <= $2.00Price Change Pct: <= $-5.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Venus Concept Inc

3.51M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Surgepays Inc

25.72M

stocks with an rsi under 5

Intellectia · 221 candidates

Rsi Category: oversold

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Innovation Beverage Group Ltd

3.33M

Surgepays Inc

25.72M

Four Seasons Education (Cayman) Inc

17.36M

J-Long Group Ltd

13.50M

with an rsi under 10

Intellectia · 221 candidates

Rsi Category: oversold

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Innovation Beverage Group Ltd

3.33M

Surgepays Inc

25.72M

Four Seasons Education (Cayman) Inc

17.36M

J-Long Group Ltd

13.50M

stocks that fell over 20% yesterday

Intellectia · 19 candidates

Price Change Pct: $-100.00 - $-20.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Venus Concept Inc

3.51M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Surgepays Inc

25.72M

stock to buy low and sell high today

Intellectia · 10 candidates

Relative Vol: >= 2Pe Ttm: <= 15Rsi 14: <= 25Moving Average Relationship: PriceBelowMA20Week Price Change Pct: <= $-3.00

Ticker

Name

Market Cap$

Diginex Ltd

292.33M

Net Lease Office Properties

279.84M

iHuman Inc

92.42M

IO Biotech Inc

14.94M

J-Long Group Ltd

13.50M

Future Fintech Group Inc

10.55M

Whales Holding PBM

Trading Trends

People Also Watch

Frequently Asked Questions

What is Psyence Biomedical Ltd (PBM) stock price today?

The current price of PBM is 7.5999999 USD — it has increased 29.47

What is Psyence Biomedical Ltd (PBM)'s business?

Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

What is the price predicton of PBM Stock?

Wall Street analysts forecast PBM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PBM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Psyence Biomedical Ltd (PBM)'s revenue for the last quarter?

Psyence Biomedical Ltd revenue for the last quarter amounts to -1.51M USD, increased 30.18

What is Psyence Biomedical Ltd (PBM)'s earnings per share (EPS) for the last quarter?

Psyence Biomedical Ltd. EPS for the last quarter amounts to -251456.00 USD, decreased

How many employees does Psyence Biomedical Ltd (PBM). have?

Psyence Biomedical Ltd (PBM) has 12 emplpoyees as of April 20 2026.

What is Psyence Biomedical Ltd (PBM) market cap?

Today PBM has the market capitalization of 8.72M USD.